Gregory Biedermann, MD - MU Health Care

Dr. Gregory Biedermann, MD

Claim this profile

University of Missouri - Ellis Fischel

Studies Brain Tumor
Studies Parotid Gland Cancer
10 reported clinical trials
33 drugs studied

Area of expertise

1Brain Tumor
Gregory Biedermann, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
IDH positive
1p/19q co-deletion positive
Stage IV
2Parotid Gland Cancer
Gregory Biedermann, MD has run 2 trials for Parotid Gland Cancer. Some of their research focus areas include:
p16 positive
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
University Of Missouri - Ellis Fischel
Image of trial facility.
MU Health - University Hospital/Ellis Fischel Cancer Center

Clinical Trials Gregory Biedermann, MD is currently running

Image of trial facility.

Chemotherapy + Reduced-Dose Radiation

for Throat Cancer

This trial will explore giving standard dose chemotherapy and radiation therapy to sites of disease including all lymph nodes involved with HPV-positive oropharyngeal cancer, but administer lower doses of radiation therapy to the lymph nodes that are not known to be involved with cancer. By doing so, it is hypothesized that there will be equally good long term loco-regional and distant disease control but will reduced long term treatment side effects and improved quality of life in persons living well beyond their cancer treatment.
Recruiting1 award Phase 226 criteria
Image of trial facility.

Hormone + Radiation Therapy

for Prostate Cancer

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria

More about Gregory Biedermann, MD

Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Gregory Biedermann, MD has experience with
  • Radiation Therapy
  • Degarelix
  • Histrelin
  • Bicalutamide
  • Leuprolide
  • Triptorelin
Breakdown of trials Gregory Biedermann, MD has run
Brain Tumor
Parotid Gland Cancer
Breast Cancer
Prostate Adenocarcinoma
Metastases

Other Doctors you might be interested in

Jaffar Ahmad Al HilliUniversity of Missouri - Ellis Fischel
Kushal NahaUniversity of Missouri - Ellis Fischel
Katie Murray, DO, MS, SACSUniversity of Missouri - Ellis Fischel

Frequently asked questions

Do I need insurance to participate in a trial?
What does Gregory Biedermann, MD specialize in?
Is Gregory Biedermann, MD currently recruiting for clinical trials?
Are there any treatments that Gregory Biedermann, MD has studied deeply?
What is the best way to schedule an appointment with Gregory Biedermann, MD?
What is the office address of Gregory Biedermann, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security